These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 93588)

  • 41. Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine.
    Sirtori C; Hurwitz A; Azarnoff DL
    Am J Med Sci; 1971 Jun; 261(6):341-9. PubMed ID: 4948438
    [No Abstract]   [Full Text] [Related]  

  • 42. Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: no interaction of mazindol with methysergide.
    Kirby MJ; Turner P
    Br J Clin Pharmacol; 1977 Aug; 4(4):459-61. PubMed ID: 901738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin sensitivity among obese children and adolescents, according to degree of weight loss.
    Reinehr T; Kiess W; Kapellen T; Andler W
    Pediatrics; 2004 Dec; 114(6):1569-73. PubMed ID: 15574616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and basic aspects of an anorexiant, mazindol, as an antiobesity agent in Japan.
    Inoue S; Egawa M; Satoh S; Saito M; Suzuki H; Kumahara Y; Abe M; Kumagai A; Goto Y; Shizume K
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):199S-202S. PubMed ID: 1728834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decrease in serum free triiodothyronine, thyroxine-binding globulin and thyroxine-binding prealbumin whilst taking a very-low-calorie diet.
    Stokholm KH
    Int J Obes; 1980; 4(2):133-8. PubMed ID: 6772585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacological action of mazindol on behaviors and metabolism].
    Nagai K; Mori T; Ookura M; Tsujimoto H; Nakagawa H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):133-45. PubMed ID: 6745804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of weight loss on resting energy expenditure in obese prepubertal children.
    Maffeis C; Schutz Y; Pinelli L
    Int J Obes Relat Metab Disord; 1992 Jan; 16(1):41-7. PubMed ID: 1314243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
    Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoreative insulin in obesity of adult women.
    Rath R; Slabochova Z; Vondra K
    Int J Obes; 1977; 1(3):279-86. PubMed ID: 617339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum concentrations of total and free thyroid hormones in moderately obese women during a six-week slimming cure.
    Chomard P; Vernhes G; Autissier N; Debry G
    Eur J Clin Nutr; 1988 Apr; 42(4):285-93. PubMed ID: 3396520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of a combined diet-training program on the insulin sensitivity of obese persons with normal or disordered glucose tolerance].
    Ratzmann KP; Zander E; Witt S; Schulz B
    Z Gesamte Inn Med; 1982 May; 37(10):304-8. PubMed ID: 7048770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mazindol (AN 448 Sandoz) in ambulatory treatment of obesity; its effect on body composition and adipose tissue].
    Rath R; Vondra K; Wenkeová J
    Cesk Gastroenterol Vyz; 1977 Sep; 31(6):389-94. PubMed ID: 589677
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin sensitivity and lipid levels in obese subjects after slimming diets with different complex and simple carbohydrate content.
    Piatti PM; Pontiroli AE; Saibene A; Santambrogio G; Paroni R; Magni F; Galli-Kienle M; Mistrali S; Monti LD; Pozza G
    Int J Obes Relat Metab Disord; 1993 Jul; 17(7):375-81. PubMed ID: 8395472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of mazindol on dystrophic mice and on growth in young rats.
    Coakley JH; Jackson MJ; Wagenmakers AJ; Ensor D; Edwards RH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 92(2):385-9. PubMed ID: 2565192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some recent findings in obesity.
    Masek J; Rath R; Vondra K
    Bibl Nutr Dieta; 1978; (26):85-90. PubMed ID: 623637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R
    Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

  • 59. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR; Ballard IM; Gold JA
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of acute administration of mazindol on brain energy metabolism in adult mice.
    Gonçalves CL; Scaini G; Rezin GT; Jeremias IC; Bez GD; Daufenbach JF; Gomes LM; Ferreira GK; Zugno AI; Streck EL
    Acta Neuropsychiatr; 2014 Jun; 26(3):146-54. PubMed ID: 25142190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.